Affimed N.V. (NASDAQ:AFMD) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ET
Company Participants
Alex Fudukidis – Head of Investor Relations & Director of Investor Relations
Shawn Leland – Chief Executive Officer
Andreas Harstrick – Chief Medical Officer
Michael Wolf – Head of Finance & Administration
Conference Call Participants
Li Watsek – Cantor
Daina Graybosch – Leerink Partners
Yanan Zhu – Wells Fargo
Li Chen – HC Wainright
Yale Jen – Laidlaw & Company
Dara Azar – Stifel
Operator
Good day, everyone. And welcome to Affimed’s Third Quarter 2024 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, today’s conference call is being recorded. I would now like to introduce your host for today’s call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Alex Fudukidis
Thank you, Lisa. And thank you all for joining us today for our third quarter 2024 update call. Before we begin, I’d like to remind everyone that we posted the relevant press release and presentation we’ll be using today on the Investor Relations section of the website.
On the call today, we have members of our management team, including Shawn Leland, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Harry Welten, our Consulting Chief Financial Officer. Our financials today will be presented by our VP of Finance, Michael Wolf. The team will be available for Q&A after the prepared remarks.
Before we start, I would like to remind you that today’s presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking
Read the full article here
